Extrait

This is a 9 week, multicentre, randomized, double-blind, placebo-controlled trial with two parallel groups. There is also an open-label extension phase of 18 weeks. Both medications to be used in the study, clozapine and risperidone, are fully approved for the treatment of schizophrenia.

Critère d'inclusion

• Psychosis, Schizophrenia

Liens

• nct
• ictrp
• isrctn